ActivBiotics, Inc. and Metaphore Pharmaceuticals, Inc. Sign Definitive Merger Agreement

Combined Company to Focus on Significant Infectious Disease and Inflammation Markets

16-Dec-2005

ActivBiotics, Inc. and Metaphore Pharmaceuticals, Inc. announced that the two private companies have signed a definitive merger agreement. The transaction, if completed, will result in Metaphore becoming a wholly owned subsidiary of ActivBiotics. The proposed merger is subject to approval of the stockholders of both ActivBiotics and Metaphore and is expected to close by the end of December or early January. US operations will be consolidated in Lexington, MA. Steve Gilman Ph.D., ActivBiotics' President and Chief Executive Officer, will lead the combined company which will retain the name ActivBiotics.

Other news from the department business & finance

More news from our other portals

All FT-IR spectrometer manufacturers at a glance